Elleste Solo MX 40 micrograms Transdermal Patch
Last Updated on eMC 09-May-2016 View document | Meda Pharmaceuticals Contact details
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 09-May-2016 and displayed until Current
Reasons for adding or updating:
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 6 - date of revision
Updated on 23-Mar-2015 and displayed until 09-May-2016
Reasons for adding or updating:
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 6 - date of revision
Updated on 19-Apr-2012 and displayed until 23-Mar-2015
Reasons for adding or updating:
- Change to warnings or special precautions for use
- Change to side-effects
- Change to drug interactions
Updated on 12-Dec-2008 and displayed until 19-Apr-2012
Reasons for adding or updating:
- Change due to user-testing of patient information
Updated on 16-Sep-2008 and displayed until 12-Dec-2008
Reasons for adding or updating:
- New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
Meda Pharmaceuticals
Sky Way House, Parsonage Road, Takeley, Bishop's Stortford, CM22 6PU
0845 460 0002
+44 (0)1748 828 810
0845 460 0000
+44 (0)1748 828 810
+44 (0)1748 828 801
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue